EP3097923

REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    31.1.2008
  • EP published:
    27.7.2022
  • EP application number:
    16177278.5
  • Max expiry date:
    30.1.2028
  • Title in English:
    REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE
  • Language of the patent:
    English

Timeline

Today
31.1.2008EP application
27.7.2022EP Publication

Owner

  • Name:
    YEDA RESEARCH AND DEVELOPMENT CO., LTD.
  • Address:
    The Weizmann Institute of Science, P.O. Box 95, 76100 Rehovot, IL

Inventor

  • Name:
    ESHHAR, Zelig
  • Address:
    76100 Rehovot, IL
  • Name:
    ELINAV, Eran
  • Address:
    93715 Jerusalem, IL

Priority

  • Number:
    898408 P
  • Date:
    31.1.2007
  • Country:
    US
  • Number:
    951052 P
  • Date:
    20.7.2007
  • Country:
    US

Classification

  • Categories:
    C12N 5/0783, A61K 39/00, A61P 29/00, A61P 37/00

Upload documents